Assessing bcg vaccination coverage and incidence of paediatric tuberculosis following two major changes in bcg vaccination policy in France

Eurosurveillance

Volumn 16, Issue 12, 2011, Pages

  Guthmann, J P ^a   Antoine, D ^a   Fonteneau, L ^a   Che, D ^a   Levy Bruhl D ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; BCG VACCINATION; CHILD; COMMERCIAL PHENOMENA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FOLLOW UP; FRANCE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIVATE PRACTICE; RETROSPECTIVE STUDY; TUBERCULOSIS;

EID: 79953289980     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Conseil supérieur d'hygiène publique de France. [Vaccination schedule for 2005]. Bull Epidémiol Hebd. 2005; 29-30: 141-7. French.
2. World Health Organization (WHO). BCG vaccine. WHO position paper. Wkly Epidemiol Rec. 2004;79(4):27-38.
3. de La Rocque F, Cohen R, Vie Le Sage F, Bocquet A, Boucherat M, Levy Bruhl D. [French paediatrician and general practitioner's survey about actual and future BCG use]. Arch Pediatr. 2005;12(11):1665-9. French.
4. Manaouil C, Garnier C, Gignon M, Jardé O. [Tuberculosis vaccination programs: where are we?]. Arch Pediatr. 2008;15(6):1100-6. French.
5. Lévy-Bruhl D, Paty MC, Antoine D, Bessette D. Recent changes in tuberculosis control and BCG vaccination policy in France. Euro Surveill. 2007;12(37):pii=3268. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3268
6. Haut conseil de la santé publique. [Vaccination schedule for 2007 and recommendations published since the 2006 vaccination schedule]. Bull Epidémiol Hebd; 2007;31-32:271-7. French.
7. Lévy-Bruhl D. Prospects for the BCG vaccination programme in France. Euro Surveill. 2006;11(3):pii=605. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=605
8. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease. Tuber Lung Dis. 1994;75(3):179-80.
9. Antoine D, Che D. Tuberculosis cases notified in France in 2005. Bull Epidémiol Hebd. 2007;11:85-9. French.
10. Antoine D, Che D. Epidemiology of tuberculosis in France: cases reported in 2008. Bull Epidemiol Hebd. 2010;27-28:289-93. French.
11. Fonteneau L, Guthmann JP, Collet M, Vilain A, Herbet JB, Lévy-Bruhl D. Vaccination coverage estimated based on data found in 24th month health certificates of infants, France, 2004-2007. Bull Epidemiol Hebd. 2010;31-32:329-3. French.
12. Guthmann JP, de La Rocque F, Boucherat M, van Cauteren D, Fonteneau L, Lécuyer A, Cohen R, Lévy-Bruhl D. [BCG vaccine coverage in private medical practice: First data in children below two years old, seven months after the end of compulsory vaccination in France]. Arch Pediatr. 2009;16(5):489-95. French.
13. Guthmann JP, Fonteneau L, Desplanques L, Lévy-Bruhl D. [BCG vaccination coverage in children born after the end of compulsory BCG vaccination and followed in maternal and child health clinics in France: a national survey 2009]. Arch Pediatr. 2010;17(9):1281-7. French.
14. Guthmann JP, Fonteneau L, Antoine D, Cohen R, Lévy-Bruhl D, Che D. [BCG vaccination coverage and epidemiology of tuberculosis in children: where do we stand one year after suspending mandatory immunization, in France?]. Bull Epidemiol Hebd. 2009; 12-13:113-6. French.
15. Romanus V. First experience with BCG discontinuation in Europe. Experience in Sweden 15 years after stopping general BCG vaccination at birth. Bull Int Union Tuberc Lung Dis. 1990;65(2-3):32-5.
16. Romanus V, Svensson A, Hallander HO. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989. Tuber Lung Dis. 1992;73(3):150-61.
17. Manissero D, Lopalco PL, Levy-Bruhl D, Ciofi Degli Atti ML, Giesecke J. Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings. Vaccine. 2008;26(18):2253-59.
18. Lévy-Bruhl D. [Estimation of the epidemiological impact of various BCG vaccination scenarios in France]. Rev Epidemiol Sante Publique. 2005;53(5):501-8. French.
19. Jakab Z. Tuberculosis in the European Union - ongoing commitment needed to control the disease. Euro Surveill. 2009;14(11):pii=19150. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19150
20. Watson JM. Tuberculosis and BCG in Europe. Euro Surveill. 2006;11(3):pii=603. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=603